NCT00939783 An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT00939770 Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00939562 Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate Status COMPLETED Phase PHASE4
NCT00939185 Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections Status COMPLETED Phase N/A
NCT00939120 Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) Status COMPLETED Phase PHASE4
NCT00938587 A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00938301 A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT00938015 Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis Status COMPLETED Phase N/A
NCT00937352 A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT00936871 The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects Status COMPLETED Phase PHASE1
NCT00936559 Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair Status TERMINATED Phase PHASE1
NCT00936065 Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE4
NCT00935012 Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy Status COMPLETED Phase PHASE3
NCT00934934 Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment Status TERMINATED Phase PHASE2
NCT00934089 A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 Status COMPLETED Phase PHASE2
NCT00932893 An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene Status COMPLETED Phase PHASE3
NCT00932451 An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene Status COMPLETED Phase PHASE2
NCT00932165 Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin Status COMPLETED Phase N/A